- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02067364
CRT ShuntCheck "Fit & Function" Study
CRT ShuntCheck "Fit & Function" Exploratory Study
Study Overview
Detailed Description
An exploratory "Fit & Function" study of Continuous Real Time (CRT) ShuntCheck, a non-invasive method for monitoring changes in CSF shunt flow in hydrocephalus patients. This study will gather information to refine the design of the CRT ShuntCheck sensor. Our Aim I product work will yield a clinic-ready prototype which adheres well to human skin, conforms to the curve surface of the clavicle and provides a safe level of skin cooling over an extended period of time. Many of the clinical uses of CRT will involve patient movement - standing up to investigate suspected overdrainage, or the simple fidgeting of children undergoing monitoring. The Aim II Fit and Function testing will most importantly identify movement-related product performance issues. If we can identify the causes of "signal noise", we can modify our sensor design to make it less susceptible to "motion artifacts".
Additionally testing will identify age/size specific issues - is the sensor small enough for use on younger children, does the looser skin of older adults generate move motion artifacts in the signal.
These studies will include 10 pediatric and 10 adult asymptomatic patients who are willing to undergo CRT ShuntCheck testing over a one hour period. Test results will not be used to guide patient care and testing will not interfere with or delay any other patient testing or care.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21215
- Recruiting
- LifeBridge Health, Sinai Hospital of Baltimore (Testing Adult Patients 35 years+)
-
Contact:
- Michael A Williams, MD
- Phone Number: 410-601-1900
- Email: michwill@lifebridgehealth.org
-
Principal Investigator:
- Michael A Williams, MD
-
Baltimore, Maryland, United States, 21287
- Recruiting
- Johns Hopkins Hospital (Testing Pediatric Patients Age 3 to 19)
-
Contact:
- George I Jallo, MD
- Phone Number: 410-955-7851
- Email: gjallo1@jhmi.edu
-
Principal Investigator:
- George I Jallo, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- For the pediatric subjects, males or females, older than three and less than 20 years of age.
- For the adult subjects, males or females, older than 35 years of age
- Parent/guardian or alert subject (age 18 or over) capable of giving consent; subject less than 18 and of assent age must give assent to participate if appropriate and required by the institution. If the subjects are incapable of giving assent, then only parent/guardian consent is required.
- Possess an unambiguously identifiable chronically indwelling ventricular shunt which crosses the clavicle.
Exclusion Criteria:
- Inability or unwillingness of the parent/guardian or alert subject to give informed consent/assent (when appropriate) as required by the Institutional Review Board.
- Study testing would interfere with emergent subject care or if the subject is scheduled to go the OR in short order.
- Presence of an interfering open wound or edema over the shunt.
Study Plan
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Fit & function test
CRT ShuntCheck sensors will be applied over the shunts of asymptomatic hydrocephalus patients.
The device will be activated, cooling the skin under the sensor.
Patients will change positions during the one hour procedure and data will be recorded.
Data will be analyzed offline to identify product performance issues due to motion.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sensor fit & function
Time Frame: Single visit one hour test procedure
|
Fit and Function testing will quantify the level and the duration of thermal changes due to patient movement compared with the level and duration of thermal changes due to changes in shunt flow.
If motion related changes are > 0.5 times the level of flow related changes, the sensor and/or the procedure will be modified to improve signal to noise to >2.0
|
Single visit one hour test procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Identify any safety issues
Time Frame: Single visit one hour test
|
The CRT ShuntCheck test is a non-invasive, non-significant risk procedure.
A small area of skin at the clavicle is cooled to and held at room temperature for an extended period of time.
Study subjects should experience zero significant adverse events and no temperature related adverse events beyond minor discomfort.
Any EA's will be addressed in design modifications.
|
Single visit one hour test
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NDxDev-CRT-2015
- R44NS074486 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hydrocephalus
-
University of Kansas Medical CenterNot yet recruitingLow Pressure Hydrocephalus
-
Umeå UniversityCompletedIdiopathic Normal Pressure Hydrocephalus
-
Uppsala University HospitalUppsala University; Swedish Society for Medical ResearchRecruitingIdiopathic Normal Pressure Hydrocephalus (INPH)Sweden
-
Johns Hopkins UniversityUniversity of Utah; Integra LifeSciences CorporationCompletedIdiopathic Normal Pressure Hydrocephalus (INPH)United States, Canada, Sweden
-
Military University Hospital, PragueRecruitingNormal Pressure HydrocephalusCzechia
-
University Hospital, ToulouseCompleted
-
Rabin Medical CenterUnknown
-
Mayo ClinicTerminatedNormal Pressure Hydrocephalus PatientsUnited States
-
Umeå UniversityCompleted
-
Dokuz Eylul UniversityRecruitingNPH (Normal Pressure Hydrocephalus)Turkey
Clinical Trials on Fit & Function test
-
University Hospital, BrestRegistre des Tumeurs Digestives du Finistère; Centre Régional de Coordination...CompletedFemale | Colonoscopy | Occult Blood | Mass Screening | Early Detection of Cancer | Colorectal Neoplasms Malignant | Middle AgedFrance
-
Centers for Disease Control and PreventionThe University of Texas Health Science Center, Houston; Wayne State University and other collaboratorsCompleted
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Hamilton Health Sciences Corporation and other collaboratorsCompletedCerebrovascular AccidentCanada
-
Second Affiliated Hospital, School of Medicine,...Timing Biotech Co.Ltd.CompletedColorectal Cancer | Adenoma | Adenomatous Polyps | Advanced AdenomaChina
-
Karolinska University HospitalCompleted
-
Chinese University of Hong KongCompleted
-
Metabiomics CorpUnknownColorectal Cancer | Colorectal Adenoma
-
Carol Davila University of Medicine and PharmacyNot yet recruitingBleeding | Polyp Colorectal
-
San Diego Veterans Healthcare SystemPathway Genomics CorpUnknown
-
Massachusetts General HospitalUniversity of California, Los Angeles; Stand Up To Cancer; Great Plains Tribal...Enrolling by invitationColorectal CancerUnited States